P

Precede Biosciences

Epigenomic liquid biopsy for cancer.

Associate Director - Alliance and Project Management

Program ManagementConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA

About the Job

Requirements

  • A bachelor's degree in a core life science discipline such as biology, genetics, or a related field is required.
  • At least 8 years of experience in alliance management, business development, or managing strategic partnerships within the diagnostics or biopharma ecosystem is required.
  • Strong presentation and interpersonal skills, including the ability to communicate across organizational levels internally and externally, are expected.
  • A proven track record of managing complex alliances, partnerships, or projects from inception through execution is required.
  • Strong negotiation skills and experience in contract management are required.
  • An operational understanding of external innovation, drug discovery, translational and development processes in a diagnostic context is required.
  • A deep understanding of clinical trial processes and biomarker application in clinical trials and drug development is required.
  • The ability to influence and collaborate effectively across diverse teams and stakeholders is required.
  • The ability to work autonomously and cooperatively in a creative, entrepreneurial, and agile team environment is required.
  • Proven experience taking initiative to solve problems and drive key outcomes is required.

Responsibilities

  • Manage designated biopharma collaborations and serve as their primary point of contact.
  • Manage the alliance lifecycle, ensuring adherence to contractual obligations with partners and compliance with company policies and legal requirements.
  • Develop and maintain program plans with internal stakeholders to ensure delivery on contractual obligations.
  • Lead day-to-day alliance activities and drive successful program, project, and alliance execution through effective internal and external communication and alignment on project goals and timelines.
  • Facilitate partnership meetings; establish deliverable and timeline goals and expectations; track and communicate progress and deviations; and prepare key documentation and reports.
  • Cultivate relationships and partnerships with internal stakeholders and collaborators to advance alliance and project goals and deliverables.
  • Drive alliance goals while considering the impact of short-term decisions on long-term success.
  • Anticipate and identify potential gaps and conflicts in contractual agreements and day-to-day execution, and construct a path forward while maintaining collaborative relationships with external partners.
  • Consult and engage internal team members and business partners, including corporate and business development, research and development, operations, and legal teams, to ensure alignment toward goals; prepare for and facilitate proactive partnership management and coordinate key project activities.
  • Update and inform senior leadership through timely alliance reviews, resource evaluation, and gap analyses.
  • Educate colleagues and share best practices to foster company-wide capability in alliance management.

Desired Qualifications

  • A master's degree or Ph.D. is preferred.
  • Experience with oncology clinical genomics, epigenomics, or liquid biopsy applications is strongly preferred.

About the Company

Precede Biosciences

Epigenomic liquid biopsy for cancer.

Precede Biosciences uses a blood test to read epigenomic signals in plasma. It analyzes circulating chromatin and the DNA methylome from a single milliliter of blood to determine the activation status of about 20,000 gene promoters and 1 million gene enhancers, providing a transcriptional biology view of disease. The platform supports drug development through Research Use Only partnerships with biopharmaceutical companies and academia, and aims to develop clinical blood-based tests that can replace invasive tissue biopsies for guiding precision medicines in cancers such as breast, lung, prostate, and colorectal. Unlike purely genomic tests, this approach focuses on epigenomic regulation to reveal disease biology, treatment response, and resistance. The company seeks to help identify therapeutic targets and mechanisms driving outcomes, with a goal of accelerating biomarker discovery and enabling non-invasive, dynamic insights into cancer biology.

Company size
51-200
Company stage
Debt Financing
Total funding
$140.5M
Headquarters
Boston, MA
Founded
2021

Recently Posted Jobs

Explore more opportunities at Precede Biosciences

See more jobs